从β独奏到内分泌交响曲:子类型完整的岛屿进行葡萄糖和
Jia Zhao1, Shenghui Liang1, Timothy J Kieffer2
1Life Sciences Institute, Department of Cellular & Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Cell stem cell
|September 5, 2025
概括
研究人员从干细胞中制造出完整的胰岛. 这些小岛恢复了天然血糖控制,并预防了糖尿病小鼠的低血糖,改善了糖尿病细胞治疗.
科学领域:
- 内分泌学
- 干细胞生物学
- 代谢疾病研究
背景情况:
- 目前用于糖尿病的干细胞疗法通常会产生富含β细胞的小岛.
- 这些疗法可以成功逆转高血糖,但可能导致危险的低血糖.
- 在工程小岛上缺乏内分泌多样性是一个潜在的限制.
研究的目的:
- 设计具有多种内分泌细胞亚型的功能完整的胰岛.
- 评估这些完整的小岛在恢复生理葡萄糖调节方面的有效性.
- 在糖尿病小鼠模型中评估抗低血糖的保护作用.
主要方法:
- 使用干细胞分化协议产生多种胰腺内分泌细胞类型.
- 重建模仿自然内分泌成分的小岛.
- 在糖尿病小鼠模型中植入工程小岛.
- 监测血糖控制和对调控激素的反应.
主要成果:
- 工程内分泌亚型完整的小岛成功生成.
- 植入的小岛恢复了对葡萄糖波动的强有力的反调节反应.
- 完整的小岛保护糖尿病小鼠免受低血糖的影响.
- 与β细胞丰富的小岛相比,这种方法提供了更好的生理调节.
结论:
- 内分泌多样性对于开发生理调节的糖尿病细胞疗法至关重要.
- 重建完整的小岛是一个有希望的策略来克服与当前干细胞治疗相关的低血糖症.
- 这项研究有助于设计更安全,更有效的糖尿病细胞疗法.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Cells and Secretions of the Pancreas
2.9K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.9K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Glucose Homeostasis: Regulation of Blood Glucose
2.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.4K
Glucagon-like Receptor Agonists
415
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
415


